# Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency

> **NCT01668433** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 20 (actual)

## Conditions studied

- G6PD Normal
- G6PD Deficient
- Healthy

## Interventions

- **DRUG:** Regimens (Primaquine, Methylene blue)

## Key facts

- **NCT ID:** NCT01668433
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01668433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01668433, "Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01668433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*